The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives
Open accessAbstract
Platinum (Pt)-based anticancer drugs such as cisplatin have been used to treat various cancers. However, they have some limitations including poor selectivity and toxicity towards normal cells and increasing chemoresistance. Therefore, there is a need for novel metallo-anticancers, which has not been met for decades. Since the initial introduction of ruthenium (Ru) polypyridyl complex, a number of attempts at structural evolution have been conducted to improve efficacy. Among them, half-sandwich Ru-arene complexes have been the most prominent as an anticancer platform. Such complexes have clearly shown superior anticancer profiles such as increased selectivity toward cancer cells and ameliorating toxicity against normal cells compared to existing Pt-based anticancers. Currently, several Ru complexes are under human clinical trials. For improvement in selectivity and toxicity associated with chemotherapy, Ru complexes as photodynamic therapy (PDT), and photoactivated chemotherapy (PACT), which can selectively activate prodrug moieties in a specific region, have also been investigated. With all these studies on these interesting entities, new metallo-anticancer drugs to at least partially replace existing Pt-based anticancers are anticipated. This review covers a brief description of Ru-based anticancer complexes and perspectives.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Photodynamic therapy for cancer
Dolmans, D. E. J. G. J., Fukumura, D., & Jain, R. K. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1071 · Cited by 6,758
Platinum Compounds: a New Class of Potent Antitumour Agents
ROSENBERG, B., VANCAMP, L., TROSKO, J. E., & MANSOUR, V. H. (1969) · Nature · doi:10.1038/222385a0 · Cited by 3,972
Ruthenium(II)-Catalyzed C–H Bond Activation and Functionalization
Arockiam, P. B., Bruneau, C., & Dixneuf, P. H. (2012) · Chemical Reviews · doi:10.1021/cr300153j · Cited by 2,743
Drug Resistance and the Solid Tumor Microenvironment
Tredan, O., Galmarini, C. M., Patel, K., & Tannock, I. F. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm135 · Cited by 2,116
Ruthenium-Based Heterocyclic Carbene-Coordinated Olefin Metathesis Catalysts
Vougioukalakis, G. C., & Grubbs, R. H. (2010) · Chemical Reviews · doi:10.1021/cr9002424 · Cited by 2,018
The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase.
Tenhunen, R., Marver, H. S., & Schmid, R. (1968) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.61.2.748 · Cited by 1,803
Current Status of Platinum-Based Antitumor Drugs
Wong, E., & Giandomenico, C. M. (1999) · Chemical Reviews · doi:10.1021/cr980420v · Cited by 1,800
Monro, S., Colón, K. L., Yin, H., Roque, J., Konda, P., Gujar, S., Thummel, R. P., Lilge, L., Cameron, C. G., & McFarland, S. A. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00211 · Cited by 1,461
A molecular light switch for DNA: Ru(bpy)2(dppz)2+
Friedman, A. E., Chambron, J. C., Sauvage, J. P., Turro, N. J., & Barton, J. K. (1990) · Journal of the American Chemical Society · doi:10.1021/ja00168a052 · Cited by 1,412
Metallodrugs in Medicinal Inorganic Chemistry
Mjos, K. D., & Orvig, C. (2014) · Chemical Reviews · doi:10.1021/cr400460s · Cited by 1,289
Zeng, L., Gupta, P., Chen, Y., Wang, E., Ji, L., Chao, H., & Chen, Z.-S. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00195a · Cited by 1,017
Rademaker-Lakhai, J. M., van den Bongard, D., Pluim, D., Beijnen, J. H., & Schellens, J. H. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0746 · Cited by 833
Hartinger, C. G., Jakupec, M. A., Zorbas‐Seifried, S., Groessl, M., Egger, A., Berger, W., Zorbas, H., Dyson, P. J., & Keppler, B. K. (2008) · Chemistry & Biodiversity · doi:10.1002/cbdv.200890195 · Cited by 830
Noble metals in medicine: Latest advances
Medici, S., Peana, M., Nurchi, V. M., Lachowicz, J. I., Crisponi, G., & Zoroddu, M. A. (2014) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2014.08.002 · Cited by 755
Gill, M. R., & Thomas, J. A. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15299a · Cited by 747
Galanski, M. S., Jakupec, M. A., & Keppler, B. K. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867054637626 · Cited by 721
NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
Trondl, R., Heffeter, P., Kowol, C. R., Jakupec, M. A., Berger, W., & Keppler, B. K. (2014) · Chem. Sci. · doi:10.1039/c3sc53243g · Cited by 675
Cardioprotective Actions by a Water-Soluble Carbon Monoxide–Releasing Molecule
Clark, J. E., Naughton, P., Shurey, S., Green, C. J., Johnson, T. R., Mann, B. E., Foresti, R., & Motterlini, R. (2003) · Circulation Research · doi:10.1161/01.res.0000084381.86567.08 · Cited by 673
Areneruthenium complexes as anticancer agents
Süß‐Fink, G. (2009) · Dalton Transactions · doi:10.1039/b916860p · Cited by 652
Classical and Non‐Classical Ruthenium‐Based Anticancer Drugs: Towards Targeted Chemotherapy
Ang, W. H., & Dyson, P. J. (2006) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.200600723 · Cited by 635
Timerbaev, A. R., Hartinger, C. G., Aleksenko, S. S., & Keppler, B. K. (2006) · Chemical Reviews · doi:10.1021/cr040704h · Cited by 614
Recent developments in ruthenium anticancer drugs
Levina, A., Mitra, A., & Lay, P. A. (2009) · Metallomics · doi:10.1039/b904071d · Cited by 592
Kuang, D., Ito, S., Wenger, B., Klein, C., Moser, J.-E., Humphry-Baker, R., Zakeeruddin, S. M., & Grätzel, M. (2006) · Journal of the American Chemical Society · doi:10.1021/ja058540p · Cited by 584
Platinum neurotoxicity pharmacogenetics
McWhinney, S. R., Goldberg, R. M., & McLeod, H. L. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0840 · Cited by 574
Combination of Ru(ii) complexes and light: new frontiers in cancer therapy
Mari, C., Pierroz, V., Ferrari, S., & Gasser, G. (2015) · Chemical Science · doi:10.1039/c4sc03759f · Cited by 570
Ruthenium Complexes as Anticancer Agents
Kostova, I. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706776360941 · Cited by 566
Clinical development of photodynamic agents and therapeutic applications
Baskaran, R., Lee, J., & Yang, S.-G. (2018) · Biomaterials Research · doi:10.1186/s40824-018-0140-z · Cited by 564
Transferrin receptors in human tissues: their distribution and possible clinical relevance.
Gatter, K. C., Brown, G., Trowbridge, I. S., Woolston, R. E., & Mason, D. Y. (1983) · Journal of Clinical Pathology · doi:10.1136/jcp.36.5.539 · Cited by 531
The potential of organometallic complexes in medicinal chemistry
Gasser, G., & Metzler-Nolte, N. (2012) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2012.01.013 · Cited by 516
Photoactivated chemotherapy (PACT): the potential of excited-state d-block metals in medicine
Farrer, N. J., Salassa, L., & Sadler, P. J. (2009) · Dalton Transactions · doi:10.1039/b917753a · Cited by 496
An integrated view of cisplatin-induced nephrotoxicity and ototoxicity
Karasawa, T., & Steyger, P. S. (2015) · Toxicology Letters · doi:10.1016/j.toxlet.2015.06.012 · Cited by 475
Ruthenium complexes as antimicrobial agents
Li, F., Collins, J. G., & Keene, F. R. (2015) · Chemical Society Reviews · doi:10.1039/c4cs00343h · Cited by 467
Huang, H., Yu, B., Zhang, P., Huang, J., Chen, Y., Gasser, G., Ji, L., & Chao, H. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201507800 · Cited by 449
Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs
Bergamo, A., & Sava, G. (2011) · Dalton Transactions · doi:10.1039/c0dt01816c · Cited by 440
Chemotherapy-induced neuropathy: A comprehensive survey
Miltenburg, N. C., & Boogerd, W. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2014.04.004 · Cited by 431
Knoll, J. D., & Turro, C. (2015) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2014.05.018 · Cited by 423
Metal based drugs: from serendipity to design
Fricker, S. P. (2007) · Dalton Transactions · doi:10.1039/b705551j · Cited by 414
Bioactive Luminescent Transition‐Metal Complexes for Biomedical Applications
Ma, D., He, H., Leung, K., Chan, D. S., & Leung, C. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201208414 · Cited by 388
DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity
Brabec, V., & Nováková, O. (2006) · Drug Resistance Updates · doi:10.1016/j.drup.2006.05.002 · Cited by 384
The path for metal complexes to a DNA target
Komor, A. C., & Barton, J. K. (2013) · Chemical Communications · doi:10.1039/c3cc00177f · Cited by 384
Organometallic ruthenium-based antitumor compounds with novel modes of action
Ang, W. H., Casini, A., Sava, G., & Dyson, P. J. (2011) · Journal of Organometallic Chemistry · doi:10.1016/j.jorganchem.2010.11.009 · Cited by 366
Platinum Anticancer Coordination Compounds: Study of DNA Binding Inspires New Drug Design
Reedijk, J. (2009) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.200900054 · Cited by 343
Phase I study of oxaliplatin in patients with advanced cancer
Extra, J. M., Espie, M., Calvo, F., Ferme, C., Mignot, L., & Marty, M. (1990) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00684890 · Cited by 343
Reedijk, B. J. (2008) · Platinum Metals Review · doi:10.1595/147106708x255987 · Cited by 312
Vasoactive properties of CORM‐3, a novel water‐soluble carbon monoxide‐releasing molecule
Foresti, R., Hammad, J., Clark, J. E., Johnson, T. R., Mann, B. E., Friebe, A., Green, C. J., & Motterlini, R. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705825 · Cited by 303
Pierroz, V., Joshi, T., Leonidova, A., Mari, C., Schur, J., Ott, I., Spiccia, L., Ferrari, S., & Gasser, G. (2012) · Journal of the American Chemical Society · doi:10.1021/ja307288s · Cited by 296
Biological Activity of Complex Ions
DWYER, F. P., GYARFAS, E. C., ROGERS, W. P., & KOCH, J. H. (1952) · Nature · doi:10.1038/170190a0 · Cited by 289
Rationally designed ruthenium complexes for 1- and 2-photon photodynamic therapy
Karges, J., Kuang, S., Maschietto, F., Blacque, O., Ciofini, I., Chao, H., & Gasser, G. (2020) · Nature Communications · doi:10.1038/s41467-020-16993-0 · Cited by 284
Liu, J., Chen, Y., Li, G., Zhang, P., Jin, C., Zeng, L., Ji, L., & Chao, H. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.04.002 · Cited by 280
A comparative study of the photosensitizing characteristics of some cyanine dyes
Delaey, E., van Laar, F., De Vos, D., Kamuhabwa, A., Jacobs, P., & de Witte, P. (2000) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/s1011-1344(00)00021-x · Cited by 270
From One‐Photon to Two‐Photon Probes: “Caged” Compounds, Actuators, and Photoswitches
Bort, G., Gallavardin, T., Ogden, D., & Dalko, P. I. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201204203 · Cited by 262
Renfrew, A. K. (2014) · Metallomics · doi:10.1039/c4mt00069b · Cited by 252
Correlation between Cytotoxicity and DNA Binding of Polypyridyl Ruthenium Complexes
Novakova, O., Kasparkova, J., Vrana, O., van Vliet, P. M., Reedijk, J., & Brabec, V. (1995) · Biochemistry · doi:10.1021/bi00038a034 · Cited by 246
Targeting Nucleus DNA with a Cyclometalated Dipyridophenazineruthenium(II) Complex
Huang, H., Zhang, P., Yu, B., Chen, Y., Wang, J., Ji, L., & Chao, H. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501095r · Cited by 230
Harnessing ruthenium(II) as photodynamic agents: Encouraging advances in cancer therapy
Liu, J., Zhang, C., Rees, T. W., Ke, L., Ji, L., & Chao, H. (2018) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2018.03.002 · Cited by 217
A Red‐Light‐Activated Ruthenium‐Caged NAMPT Inhibitor Remains Phototoxic in Hypoxic Cancer Cells
Lameijer, L. N., Ernst, D., Hopkins, S. L., Meijer, M. S., Askes, S. H. C., Le Dévédec, S. E., & Bonnet, S. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201703890 · Cited by 212
Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells
Kapitza, S., Pongratz, M., Jakupec, M. A., Heffeter, P., Berger, W., Lackinger, L., Keppler, B. K., & Marian, B. (2005) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-004-0617-0 · Cited by 200
Pettinari, R., Marchetti, F., Condello, F., Pettinari, C., Lupidi, G., Scopelliti, R., Mukhopadhyay, S., Riedel, T., & Dyson, P. J. (2014) · Organometallics · doi:10.1021/om500317b · Cited by 187
Wiegell, S. R., Haedersdal, M., Eriksen, P., & Wulf, H. C. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09119.x · Cited by 173
Frei, A., Rubbiani, R., Tubafard, S., Blacque, O., Anstaett, P., Felgenträger, A., Maisch, T., Spiccia, L., & Gasser, G. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500566f · Cited by 171
Photoactivatable metal complexes: from theory to applications in biotechnology and medicine
Smith, N. A., & Sadler, P. J. (2013) · Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences · doi:10.1098/rsta.2012.0519 · Cited by 170
Jakupec, M. A., Reisner, E., Eichinger, A., Pongratz, M., Arion, V. B., Galanski, M. S., Hartinger, C. G., & Keppler, B. K. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0490742 · Cited by 164
Chow, M. J., Licona, C., Yuan Qiang Wong, D., Pastorin, G., Gaiddon, C., & Ang, W. H. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500455p · Cited by 159
Mohamed Subarkhan, M. K., Ren, L., Xie, B., Chen, C., Wang, Y., & Wang, H. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.06.061 · Cited by 158
Coordination compounds in cancer: Past, present and perspectives
Trudu, F., Amato, F., Vaňhara, P., Pivetta, T., Peña‐Méndez, E. M., & Havel, J. (2015) · Journal of Applied Biomedicine · doi:10.1016/j.jab.2015.03.003 · Cited by 151
Yellol, J., Pérez, S. A., Buceta, A., Yellol, G. S., Donaire, A., Szumlas, P., Bednarski, P. J., Makhloufi, G., Janiak, C., Ferao, A. E., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01194 · Cited by 151
Kurzwernhart, A., Kandioller, W., Bächler, S., Bartel, C., Martić, S., Buczkowska, M., Mühlgassner, G., Jakupec, M. A., Kraatz, H., Bednarski, P. J., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301376a · Cited by 147
Wernitznig, D., Kiakos, K., Favero, G. D., Harrer, N. E., Machat, H., Oßwald, A., Jakupec, M. A., Wernitznig, A., Sommergruber, W., & Keppler, B. K. (2019) · Metallomics · doi:10.1039/c9mt00051h · Cited by 141
Groessl, M., Zava, O., & Dyson, P. J. (2011) · Metallomics · doi:10.1039/c0mt00101e · Cited by 139
Oxidation/reduction potential of glutathione
Millis, K. K., Weaver, K. H., & Rabenstein, D. L. (1993) · The Journal of Organic Chemistry · doi:10.1021/jo00067a060 · Cited by 137
Cisplatin binding to human serum albumin: a structural study
Ferraro, G., Massai, L., Luigi Messori, A., & Merlino, A. (2015) · Chemical Communications · doi:10.1039/c5cc01751c · Cited by 136
Raza, A., Archer, S. A., Fairbanks, S. D., Smitten, K. L., Botchway, S. W., Thomas, J. A., MacNeil, S., & Haycock, J. W. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.9b11313 · Cited by 130
Bijelic, A., Theiner, S., Keppler, B. K., & Rompel, A. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00600 · Cited by 128
Eisenberger, M. A., Hornedo, J., Silva, H., Donehower, R. C., Spaulding, M. B., & Echo, D. V. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.10.1506 · Cited by 125
Chen, Z., Qin, Q., Qin, J.-L., Zhou, J., Li, Y., Li, N., Liu, Y., & Liang, H. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00444 · Cited by 124
Hess, J., Huang, H., Kaiser, A., Pierroz, V., Blacque, O., Chao, H., & Gasser, G. (2017) · Chemistry - A European Journal · doi:10.1002/chem.201701392 · Cited by 121
Joshi, T., Pierroz, V., Mari, C., Gemperle, L., Ferrari, S. M., & Gasser, G. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201309576 · Cited by 119
Shi, S., Geng, X., Zhao, J., Yao, T., Wang, C., Yang, D., Zheng, L., & Ji, L. (2010) · Biochimie · doi:10.1016/j.biochi.2010.01.003 · Cited by 117
A GSH-activatable ruthenium( ii )-azo photosensitizer for two-photon photodynamic therapy
Zeng, L., Kuang, S., Li, G., Jin, C., Ji, L., & Chao, H. (2017) · Chemical Communications · doi:10.1039/c6cc10330h · Cited by 113
Berndsen, R. H., Weiss, A., Abdul, U. K., Wong, T. J., Meraldi, P., Griffioen, A. W., Dyson, P. J., & Nowak-Sliwinska, P. M. (2017) · Scientific Reports · doi:10.1038/srep43005 · Cited by 113
Groessl, M., Tsybin, Y. O., Hartinger, C. G., Keppler, B. K., & Dyson, P. J. (2010) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-010-0635-0 · Cited by 106
Arene–Ruthenium(II) Acylpyrazolonato Complexes: Apoptosis-Promoting Effects on Human Cancer Cells
Pettinari, R., Pettinari, C., Marchetti, F., Skelton, B. W., WHITE, A. H., Bonfili, L., Cuccioloni, M., Mozzicafreddo, M., Cecarini, V., Angeletti, M., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500458c · Cited by 99
Zeng, L., Chen, Y., Huang, H., Wang, J., Zhao, D., Ji, L., & Chao, H. (2015) · Chemistry - A European Journal · doi:10.1002/chem.201502154 · Cited by 95
Cook, N. P., Kilpatrick, K., Segatori, L., & Martı́, A. A. (2012) · Journal of the American Chemical Society · doi:10.1021/ja3100287 · Cited by 92
Nguyen, D., & Boyer, C. A. (2015) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5b00230 · Cited by 86
Serum-protein interactions with anticancer Ru(III) complexes KP1019 and KP418 characterized by EPR
Cetinbas, N. M., Webb, M. I., Dubland, J. A., & Walsby, C. J. (2009) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-009-0578-5 · Cited by 85
Necroptosis Induced by Ruthenium(II) Complexes as Dual Catalytic Inhibitors of Topoisomerase I/II
Xiong, K., Qian, C., Yuan, Y., Wei, L., Liao, X., He, L., Rees, T. W., Chen, Y., Wan, J., Ji, L., et al. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202006089 · Cited by 82
A luminescent ruthenium( ii ) complex for light-triggered drug release and live cell imaging
Karaoun, N., & Renfrew, A. K. (2015) · Chemical Communications · doi:10.1039/c5cc05172j · Cited by 78
Xu, W., Zuo, J., Wang, L., Ji, L., & Chao, H. (2014) · Chemical Communications · doi:10.1039/c3cc48916g · Cited by 76
Design of biomaterials for intracellular delivery of carbon monoxide
Inaba, H., Fujita, K., & Ueno, T. (2015) · Biomaterials Science · doi:10.1039/c5bm00210a · Cited by 74
Illuminating cytochrome P450 binding: Ru( ii )-caged inhibitors of CYP17A1
Li, A., Yadav, R., White, J. K., Herroon, M. K., Callahan, B. P., Podgorski, I., Turró, C., Scott, E. E., & Kodanko, J. J. (2017) · Chemical Communications · doi:10.1039/c7cc01459g · Cited by 73
Ruthenium Dioxide as Cathode Material for Hydrogen Evolution in Hydroxide and Chlorate Solutions
Cornell, A., & Simonsson, D. (1993) · Journal of The Electrochemical Society · doi:10.1149/1.2220996 · Cited by 70
Kilah, N. L., & Meggers, E. (2012) · Australian Journal of Chemistry · doi:10.1071/ch12275 · Cited by 69
Anticancer activity of structurally related ruthenium(II) cyclopentadienyl complexes
Côrte‐Real, L., Mendes, F., Coimbra, J., Morais, T. S., Tomaz, A. I., Valente, A., García, M. H., Santos, I., Bicho, M., & Marques, F. (2014) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-014-1120-y · Cited by 64
Dinuclear ruthenium( ii ) antimicrobial agents that selectively target polysomes in vivo
Li, F., Harry, E. J., Bottomley, A. L., Edstein, M. D., Birrell, G. W., Woodward, C. E., Keene, F. R., & Collins, J. G. (2013) · Chemical Science · doi:10.1039/c3sc52166d · Cited by 63
Sanna, B., Debidda, M., Pintus, G., Tadolini, B., Posadino, A. M., Bennardini, F., Sava, G., & Ventura, C. (2002) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00218-7 · Cited by 60
Hara, D., Komatsu, H., Son, A., Nishimoto, S., & Tanabe, K. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00093 · Cited by 60
Qin, Q., Wang, Z., Huang, X., Tan, M., Shi, B., & Liang, H. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00098 · Cited by 57
Ruiz, M. C., Kljun, J., Turel, I., Virgilio, A. L. D., & León, I. E. (2019) · Metallomics · doi:10.1039/c8mt00369f · Cited by 51
Luminescent Ruthenium Complexes for Theranostic Applications
Cardoso, C. R., Lima, M. V. S., Cheleski, J., Peterson, E. J., Venâncio, T., Farrell, N. P., & Carlos, R. M. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5005946 · Cited by 47
Notaro, A., Frei, A., Rubbiani, R., Jakubaszek, M., Basu, U., Koch, S., Mari, C., Dotou, M., Blacque, O., Gouyon, J., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00431 · Cited by 47
Ruthenium Polypyridine Complexes Combined with Oligonucleotides for Bioanalysis: A Review
Zhang, S., Ding, Y., & Wei, H. (2014) · Molecules · doi:10.3390/molecules190811933 · Cited by 46
Chen, Y., Lei, W., Jiang, G., Hou, Y., Li, C., Zhang, B., Zhou, Q., & Wang, X. (2014) · Dalton Transactions · doi:10.1039/c4dt01755b · Cited by 46
Synthesis and biological characterization of organoruthenium complexes with 8-hydroxyquinolines
Kljun, J., León, I. E., Peršič, Š., Cadavid-Vargas, J. F., Etcheverry, S. B., He, W., Bai, Y., & Turel, I. (2018) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2018.05.009 · Cited by 46
Donnici, C. L., Araújo, M. H., Oliveira, H. S., Moreira, D. R. M., Pereira, V. R. A., Souza, M. D. A., de Castro, M. C. A. B., & Leite, A. C. L. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.05.071 · Cited by 43
A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia
Wong, S. J., Campbell, B. H., Massey, B. L., Lynch, D. P., Cohen, E. E. W., Blair, E. A., Selle, R. M., Shklovskaya, J., Jovanovic, B. D., Skripkauskas, S., et al. (2013) · Oral Oncology · doi:10.1016/j.oraloncology.2013.05.011 · Cited by 43
Xia, Y., Chen, Q., Qin, X., Sun, D., Zhang, J., & Liu, J. (2013) · New Journal of Chemistry · doi:10.1039/c3nj00542a · Cited by 39
Acharya, S., Maji, M., Ruturaj, Purkait, K., Gupta, A., & Mukherjee, A. (2019) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.9b00853 · Cited by 38
Syntheses of Macromolecular Ruthenium Compounds: A New Approach for the Search of Anticancer Drugs
Valente, A., & García, M. H. (2014) · Inorganics · doi:10.3390/inorganics2010096 · Cited by 34
Zhang, W., Zhao, D., Zhang, R., Ye, Z., Wang, G., Yuan, J., & Yang, M. J. (2011) · The Analyst · doi:10.1039/c0an01003k · Cited by 32
Han, B.-J., Jiang, G., Wang, J., Li, W., Huang, H., & Liu, Y. (2014) · RSC Advances · doi:10.1039/c4ra07102f · Cited by 27
Yusoh, N. A., Leong, S. W., Chia, S. L., Harun, S. N., Rahman, M. B. A., Vallis, K. A., Gill, M. R., & Ahmad, H. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.9b00843 · Cited by 24
Preclinical Anticancer Activity of an Electron‐Deficient Organoruthenium(II) Complex
Soldevila‐Barreda, J. J., Azmanova, M., Pitto‐Barry, A., Cooper, P. A., Shnyder, S. D., & Barry, N. P. E. (2020) · ChemMedChem · doi:10.1002/cmdc.202000096 · Cited by 14
del Olmo, N. S., Maroto-Díaz, M., Quintana, S., Gómez, R., Hołota, M., Йонов, М., Bryszewska, M. J., Carmena, M. J., Ortega, P., & de la Mata, F. J. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112695 · Cited by 12
Cited by
Taking phototherapeutics from concept to clinical launch
Vickerman, B. M., Zywot, E. M., Tarrant, T. K., & Lawrence, D. S. (2021) · Nature Reviews Chemistry · doi:10.1038/s41570-021-00326-w · Cited by 201
Metadata
- Authors
- Lee, S. Y., Kim, C. Y., & Nam, T.-G.
- Venue
- Drug Design, Development and Therapy
- Publisher
- Informa UK Limited
- Published
- 2020-12
- Volume
- Volume 14
- Pages
- 5375-5392
- ISSN
- 1177-8881 (ISSN-L)
- OpenAlex
- W3107642212
- Cited by
- 400
- References
- 114
- FWCI
- 13.47
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.